期刊文献+

化合物模型构建在毒理学研究中的应用

Application of Chemical Models in Toxicological Study
下载PDF
导出
摘要 化学物质在给人们生活带来更加便利、舒适的同时,也给大众健康和公共安全带来了隐患。如何预测化合物的毒性,从而最大程度减少和防治化学物质的危害,是直接关系到我国顺利实施可持续发展战略与建立和谐社会的重大科学与技术问题。因此,对越来越多的新化合物的毒性进行方便、快捷和准确的预测就显得十分必要,化合物预测模型的构建在毒理学研究中具有良好的应用前景。该文综述了化合物的毒性效应、模型构建的种类以及定量构效关系在毒理学研究和实践中的应用与进展。 Human health and public safety are being threatened while chemicals bring convenience and comfortable to our life. How to reduce and avoid the hazard of chemicals via toxicity warning is becoming more and more important. Today it is necessary to estimate new chemicals conveniently, quickly and precisely. The warning model of chemicals in toxicology has a favorable prospect of application. The toxic effect and kinds of models of chemicals and the study of quantitative structure activity relationships (QSAR) in toxicity research were reviewed in this paper.
出处 《环境与健康杂志》 CAS CSCD 北大核心 2007年第9期734-736,共3页 Journal of Environment and Health
基金 国家自然科学基金资助项目(30571591)
关键词 毒性 模型构建 受体介导毒性 人类健康影响 Toxicity Models of chemicals Receptor-mediated toxicity Human health effects
  • 相关文献

参考文献19

  • 1[1]Labrie F.Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA[J].Endocr Relat Cancer,2006,13:335-355.
  • 2[2]Abbott DH,Padmanabhan V,Dumesic DA.Contributions of androgen and estrogen to fetal programming of ovarian dysfunction[J].Reprod Biol Endocrinol,2006,4:17-20.
  • 3[3]Murillo OB.Telomerase activity,estrogen receptors (alpha,beta),Bcl-2expression in human breast cancer and treatment response[J].BMC Cancer,2006,6:206-212.
  • 4[4]Hamada T,Sakuma Y.In vivo visualization of estrogen receptor alpha gene promoter activity[J].J Nippon Med Sch,2006,73:114-115.
  • 5[5]Medina FJL.Quantitative structure-activity relationship analysis of pyridinone HIV-1 reverse transcriptase inhibitors using the k nearest neighbor method and QSAR-based database mining[J].J Comput Aided Mol Des,2005,19:229-242.
  • 6[6]Brown N,Lewis RA.Exploiting QSAR methods in lead optimization[J].Curr Opin Drug Discov Devel,2006,9:419-424.
  • 7[7]Shi L,Tong W,Fang H,et al.An integrated "4-phase" approach for setting endocrine disruption screening priorities-phase Ⅰ and Ⅱ predictions of estrogen receptor binding affinity[J].SAR QSAR Environ Res,2002,13:69-88.
  • 8[8]Kamenska V,Dourmishev L.Quantitative structure-activity relationship modeling of dermatomyositis activity of drug chemicals[J].Arzneimittelforschung,2006,56:856-865.
  • 9[9]Labrie P,Maddaford SP.A comparative molecular field analysis (CoMFA)and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators[J].J Med Chem,2006,49:7646-7660.
  • 10[10]Ankley GT,Mekenyan OG,Kamenska VB et al.Reactivity profiles of ligand of mammalianretinoic acid receptors:a preliminary COREPA analysis[J].SAR QSAR Environ Res,2002,13:365-377.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部